Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPulmonologyUnitedHealthcare Thermoplasty Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentUnitedHealthcarePolicy CS014.Q

    Bronchial Thermoplasty

    Customize your policy alerts

    Sign up for UnitedHealthcare Policy CS014.Q alerts

    Get alerted when Policy CS014.Q changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of bronchial thermoplasty for asthma under the UnitedHealthcare Community Plan. The procedure is considered unproven and not medically necessary because evidence is insufficient to establish efficacy; state-specific policies or guidelines apply in specified states.

    Policy Summary
    PayerUnitedHealthcare
    PolicyBronchial Thermoplasty
    Policy CodePolicy CS014.Q
    Change TypeSupporting information and reference update
    Effective DateOctober 1, 2026
    Next Review DateN/A
    Key ActionExpect denial for bronchial thermoplasty for asthma because it is considered unproven and not medically necessary due to insufficient evidence of efficacy.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    UnprovenCoverage determination
    1Listed applicable CPT code
    6 RCTsEvidence base
    2.95 IRRProcedural-period severe exacerbations
    5.98 IRR

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Serious respiratory adverse events

    Coverage Criteria

    Bronchial Thermoplasty for Asthma

    Bronchial thermoplasty is not covered under this policy for treating asthma.

    Coverage determination: Bronchial thermoplasty is unproven and not medically necessary for treating asthma due to insufficient evidence of efficacy.

    No affirmative clinical eligibility criteria are provided.

    Bronchial thermoplasty is not medically necessary for treating asthma because the available evidence is insufficient to establish its efficacy. Accordingly, the procedure is considered unproven and not covered under this policy.

    Coding Information

    Bronchial ThermoplastyCPT
    31661Bronchoscopy, rigid or flexible, including fluoroscopic guidance, when performed; with bronchial thermoplasty, 2 or more lobes
    FDA Product CodeFDA
    OOYFDA product code for bronchial thermoplasty systems

    Provider Actions

    Denial Risk

    Procedure considered unproven and not medically necessary

    Bronchial thermoplasty for treating asthma is subject to denial because it is considered unproven and not medically necessary due to insufficient evidence of efficacy.

    Denial Risk

    FDA approval does not establish coverage

    FDA approval alone is not a basis for coverage. The FDA information and product code are provided for informational purposes only and do not establish reimbursement.

    Clinical Background

    Asthma is a heterogeneous disease generally characterized by chronic airway inflammation, variable symptoms, and expiratory airflow limitation.

    Definitions

    Bronchial Thermoplasty
    Procedure typeMinimally invasive procedure
    Intended populationAdults with severe, persistent asthma that is not well controlled with medications
    MechanismUses thermal radiofrequency energy to reduce airway smooth muscle mass and responsiveness
    Treatment scheduleAdministered at three outpatient visits approximately 3 weeks apart
    Procedure descriptionA flexible bronchoscope is introduced through the nose or mouth into the lungs, and a specialized catheter delivers controlled thermal radiofrequency energy to the targeted airway wall while leaving surrounding tissue undamaged
    Policy Summary
    PayerUnitedHealthcare
    PolicyBronchial Thermoplasty
    Policy CodePolicy CS014.Q
    Change TypeSupporting information and reference update
    Effective DateOctober 1, 2026
    Next Review DateN/A
    Key ActionExpect denial for bronchial thermoplasty for asthma because it is considered unproven and not medically necessary due to insufficient evidence of efficacy.
    SourceLink
    On This Page
    Coverage CriteriaCoding InformationProvider ActionsClinical BackgroundDefinitions